Human induced pluripotent stem cell-derived cardiomyocytes (hipsc-CMS) terrestrially fabricated into physiologically relevant 3D engineered heart tissues (ehts) will be studied aboard the…
Active Awarded Last action
- Contract number
- 80JSC025F7032
- Awardee
-
The Regents Of The University Of Colorado UEI SPVKK1RC2MZ3
- Awarding agency
-
Johnson Space Center
National Aeronautics and Space Administration
- Obligated
- $450,000
Award facts
- Contract value 100% obligated
- $450,000.00 Current and potential, with all options
- Completion date 83% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Boulder, CO 80309, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $100,000 | |
| Funding Only Action | $125,000 | |
| Other Administrative Action | $0 | |
| Original award | $225,000 |
About this award
The University of Colorado has received a $450,000 firm fixed-price delivery order from NASA's Johnson Space Center to conduct microgravity research aboard the International Space Station. The project involves studying human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) that will be fabricated into physiologically relevant three-dimensional engineered heart tissues (EHTs) and tested in the microgravity environment. The work is scheduled for completion by February 20, 2027, and will be performed at the university's Boulder, Colorado campus. This delivery order was awarded without set-aside designation, reflecting the university's competitive standing in specialized space life sciences research.
This delivery order is issued under the University of Colorado's existing $15 million Indefinite Delivery Contract with NASA's Johnson Space Center for Low Earth Orbit Space Life Science Research Platform services. The IDV structure, which extends through July 2030, enables NASA to issue targeted delivery orders for specific research initiatives while maintaining flexibility in resource allocation. The hiPSC-CM research aligns with NASA's broader space life sciences portfolio, which leverages the unique microgravity environment of the ISS to advance understanding of cellular behavior and develop innovative therapies that would benefit human health both in space and on Earth.
Description
Human induced pluripotent stem cell-derived cardiomyocytes (hipsc-CMS) terrestrially fabricated into physiologically relevant 3D engineered heart tissues (ehts) will be studied aboard the international space station (ISS).
Quick answers
Who was awarded contract 80JSC025F7032?
80JSC025F7032 was awarded to The Regents Of The University Of Colorado by Johnson Space Center (National Aeronautics and Space Administration) on January 29, 2025.
How much is contract 80JSC025F7032 worth?
The government has obligated $450,000 on 80JSC025F7032.
Is contract 80JSC025F7032 an order under another contract?
Yes. 80JSC025F7032 is a delivery order under 80JSC019D0026, an indefinite delivery contract.
Was contract 80JSC025F7032 competed?
The extent of competition for 80JSC025F7032 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award